Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2007;60:936-938; doi:10.1136/jcp.2006.044750
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

CASE REPORTS

Leucocyte common antigen (CD45) and CD5 positivity in an "undifferentiated" carcinoma: a potential diagnostic pitfall

Nyethane Ngo1, Kaushik Patel2, Peter G Isaacson3, Kikkeri N Naresh4

1 Department of Histopathology, Hammersmith Hospital, Imperial College, London, UK
2 Department of Histopathology, Kingston Hospital, London, UK
3 Department of Histopathology, University College, London, UK
4 Department of Histopathology, Hammersmith Hospital, Imperial College, London, UK

Correspondence to:
Correspondence to:
Professor K N Naresh
Department of Histopathology, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK; k.naresh@imperial.ac.uk

Accepted 3 November 2006

The first 150 words of the full text of this article appear below.

CD45 is a transmembrane protein tyrosine phosphatase located on most haematopoietic cells. It has several isoforms, and haematopoietic cells express one or more of the isoforms—CD45RO, CD45RA and CD45RB.1,2 CD45 immunoreactivity is recognised to be highly specific for non–Hodgkin’s lymphomas.3,4 CD45-expressing non-haemopoietic tumours are very rare. This was first noted by McDonnell et al5 in 1987, who reported a primitive sarcoma expressing CD45. Subsequently, Nandedkar et al6 reported three cases of undifferentiated large-cell, possibly neuroendocrine, carcinomas expressing CD45. Two of them were lymph node metastasis and one was a pulmonary tumour. All the three cases expressed both CD45 and cytokeratin. Two of the cases behaved in an aggressive manner.6

In contrast to CD45, CD5 is expressed in thymic carcinoma and malignant mesothelioma.7,8 To the best of our knowledge, this is the first reported case of a carcinoma expressing both CD45 and CD5.

Case report

We report a patient in their 60s who . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Ando, S., Abe, R., Sasaki, M., Murata, J., Inokuma, D., Shimizu, H. (2009). Bone Marrow-Derived Cells Are Not the Origin of the Cancer Stem Cells in Ultraviolet-Induced Skin Cancer. Am. J. Pathol. 174: 595-601 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs